Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Filings indexed 378 across all filing types
Latest filing 2020-03-20 Major Shareholding Noti…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Lee Whan-chul) and their special related parties, including the purpose of holding (management participation) and details of stock collateral contracts. This falls under the category of Major Shareholding Notification.
2020-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed with the Korean Exchange (KRX). It provides the auditor's opinion (적정 - unqualified), financial highlights (assets, liabilities, revenue, profit), and reconciliations between previously announced figures and the final audited figures. While it contains financial data, it is a regulatory filing announcing the submission of the audit report rather than the full annual report itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2019
2020-03-18 Korean
증권발행결과(자율공시)(제1회차 CB)
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Issuance Result' (증권 발행결과) filing from L&C Bio, detailing the completion of a private placement of convertible bonds (CB). This falls under the category of capital structure changes and financing activities. Since it specifically reports the result of a securities issuance, it aligns with the 'Capital/Financing Update' category.
2020-03-16 Korean
증권발행결과(자율공시)(제1회차 BW)
Capital/Financing Update Classification · 98% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a private placement of bonds with warrants (BW). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt/equity instruments.
2020-03-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership (including special related parties), and the purpose of holding (management participation). This corresponds to the 'Major Shareholding Notification' category.
2020-03-13 Korean
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is a formal announcement of an upcoming Investor Relations (IR) event (Non-Deal Roadshow) scheduled for March 23, 2020. It provides details such as the date, location, purpose, and agenda items for the meeting with institutional investors. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into the specific report categories, it is classified as a Regulatory Filing (RNS) which serves as the standard category for such corporate event notifications in this taxonomy.
2020-03-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.